Methicillin-susceptible, Doxycycline-resistant Staphylococcus aureus, Côte d’Ivoire by Lesens, Olivier et al.
Methicillin-
susceptible,
Doxycycline-
resistant
Staphylococcus
aureus, Côte d’Ivoire
Olivier Lesens,* Rachel Haus-Cheymol,†
Philippe Dubrous,‡ Catherine Verret,† 
André Spiegel,† Richard Bonnet,* Michèle Bes,§
Henri Laurichesse,* Jean Beytout,* 
Jerome Etienne,§ René Migliani,¶ 
Jean Louis Koeck,‡ and the Working Group on
Cutaneous Infections in the Army 
We report 2 outbreaks of Panton-Valentine leuko-
cidin–positive, doxycycline-resistant, methicillin-suscepti-
ble  Staphylococcus aureus infections in French soldiers
operating in Côte d’Ivoire. In a transssectional survey,
nasal carriage of this strain was found in 2.9% of 273 sol-
diers about to be sent to Côte d’Ivoire and was associated
with prior malaria prophylaxis with doxycycline.
S
taphylococcus aureus strains that produce Panton-
Valentine leukocidin (PVL) have been shown to be
associated with community-acquired infections such as
skin and soft tissue infections and necrotizing pneumonia
(1). A limited number of PVL-positive, methicillin-resist-
ant S. aureus (MRSA) clones have recently emerged glob-
ally (2) and have been described as causing epidemic
community-acquired infections (3,4). In contrast, PVL-
positive, methicillin-susceptible S. aureus (MSSA) corre-
sponds to many diverse clones (5) that may cause sporadic
infections with limited dissemination. We describe severe
staphylococcal infections due to a clone of doxycycline-
resistant, PVL-positive (doxyR-PVL+) MSSA in soldiers
who served in Côte d’Ivoire.
The Study
During 2004 and 2005, 4 soldiers with recurrent cuta-
neous infections related to doxycycline-resistant MSSA
(DoxyR-MSSA) visited the Centre Hospitalier Universitaire
in Clermont-Ferrand, France. The soldiers belonged to 2
companies, A and B, based at different places in France
(Clermont-Ferrand and Brives, respectively), and had been
to Côte d’Ivoire at 2 distinct periods. In October 2005, a
health warning was sent to French military authorities. We
conducted retrospective interviews of soldiers in company
A and performed a transsectional nasal carriage survey of
273 soldiers in company B, who were about to be sent to
Côte d’Ivoire. We defined case-patients as soldiers who
had had at least 1 cutaneous infection during or after their
time in Côte d’Ivoire. Information was collected from
company A case-patients by telephone interview and, for
hospitalized soldiers, chart review. 
When available, staphylococcal strains were sent to
the French National Reference Centre for Staphylococci in
Lyon, France. Sequences specific for staphylococcal
enterotoxin genes (sea-e, seh, sek, sem, sel, and seo), the
PVL genes (lukS-PV-lukF-PV), and accessory gene regu-
lator alleles (agr 1–4) were detected by PCR (6–8).
Fingerprinting by pulsed-field gel electrophoresis, spa typ-
ing, and multilocus sequence typing were performed as
described (9).
Company A comprised 70 French soldiers who had
taken doxycycline, 100 mg per day, for malaria prophylax-
is while in Côte d’Ivoire (August–November 2003).
During their 3 weeks in training camp, each soldier stayed
in 1 of 4 rooms. Of 13 soldiers who stayed in room 3, 8
(61.5%) reported having had at least 1 cutaneous infection
while in Côte d’Ivoire, compared with none of 2 soldiers
in room 1, 1 (8%) of 13 in room 2, and 7 (18%) of 39 in
room 4. Two soldiers (1A and 2A) visited our clinic in
November 2004 for treatment of abscesses that required
surgical debridement for 1 year. For each patient, doxyR-
MSSA was isolated from the abscess in a site acting as a
reservoir (nasal or perianal skin). Their conditions were
successfully treated with topical application of mupirocin
to the reservoir site. No recurrence occurred after a year.
Another soldier from company A(patient 3A) was found to
be an asymptomatic nasal carrier of doxyR-MSSA. His
wife (patient 4A) experienced several recurrent doxyR-
MSSAabscesses, including 1 that was debrided at our hos-
pital in January 2004.
In company B, ≈70 soldiers had served in Côte
d’Ivoire during October 2004–February 2005 and stayed
for 6 weeks in the same training camp that company A
stayed in the year before. Two soldiers (1B and 2B) visit-
ed our hospital. Patient 1B was hospitalized with furuncu-
losis and osteomyelitis of the left femoral diaphysis 5
months after attending training camp (and 1 month after he
returned to France). Surgically removed bone samples
contained S. aureus isolates that had profile characteristics
similar to those obtained from furuncles (Figure). Patient
2B visited our clinic in March 2005 for recurrent axillary
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experience recurrence after MSSA eradication from the
nasal and axillary reservoirs. In September 2005, recurrent
furunculosis developed in a third soldier (3B), who had not
gone to Côte d’Ivoire but who was in close contact with
soldiers returning from there. In April 2005 and December
2005, doxyR-MSSA–related recurrent abscesses devel-
oped in his wife and their 5-year-old child. 
To estimate the prevalence of PVL-positive MSSA
carriage in soldiers, nasal culture specimens were collect-
ed on May 9 and 10, 2005, from 273 soldiers in company
B (a total of 1,100 soldiers) who were about to be sent to
Côte d’Ivoire. Of these 273 soldiers, 98 (35.9%) were col-
onized with S. aureus. Among them, 28 (10%) were carri-
ers of PVL–doxyR-MSSA and 8 (2.9%) were carriers of
PVL+doxyR-MSSA. These PVL+doxyR-MSSA isolates
belonged to the same clone as those found in patients 2A,
1B, and 2B. All the MSSA isolates were considered to
belong to the same clone as they shared a large core of
common genetic characteristics (Figure). All PVL+doxyR-
MSSA carriers had been to Côte d’Ivoire and had taken
doxycycline for malaria prophylaxis (Table).
Conclusions
We characterized 2 outbreaks caused by the same
clone of PVL+doxyR-MSSA. These outbreaks occurred in
2 military companies that served in Côte d’Ivoire at differ-
ent times and whose soldiers received doxycycline for
malaria prophylaxis. This epidemic MSSA clone was
responsible for infections traditionally associated with
PVL, mainly skin and soft tissue infections, but also deep-
seated infections such as severe osteomyelitis. Since these
outbreaks, several similar cases affecting different compa-
nies who had been to Côte d’Ivoire have been reported to
the French military authorities (Figure). Another striking
feature was the spread of the clone within families after the
soldiers’return from Côte d’Ivoire. This virulent clone has
already disseminated to different continents. Analysis of
the database of the French National Reference Centre for
Staphylococci (which contains the characteristics of
≈5,000 S. aureus strains worldwide) found 25 methicillin-
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Figure. Dendogram constructed from the schematic representa-
tion of the pulsed-field gel electrophoresis types of 4 epidemic
methicillin-susceptible  Staphylococcus aureus (MSSA) isolates
included in this study (patients 2A, 1B, and 2B); 1 strain subse-
quently isolated from an abscess in a soldier belonging to compa-
ny A, who had been in Côte d'Ivoire in October 2005 (patient b);
and 3 MSSA strains isolated from abscesses in soldiers belonging
to a company other than A or B (patients a, c, d).  Isolates from all
patients had the following genetic characteristics: agr type 3, pos-
itive for Panton-Valentine leukocidin, negative for mecA gene, and
toxin genes sea, seh, and sek. In addition, isolates from patients a
and 1B were sequence type 1 and spa type 590.susceptible isolates with identical toxin gene content and
agr type from unrelated patients from Africa, Polynesia,
and France (data not shown).
Our study has limitations. The investigation conduct-
ed in company A was retrospective, so we could not con-
trol for other pathogens. Recall bias may have occurred,
and the incidence of cutaneous infections in company A
could have been underestimated. However, epidemiologic
links between case-patients were well established. Only
case-patients who visited our hospital were documented,
but they enabled recognition of the outbreaks. Recent sim-
ilar cases in soldiers who visited our hospital for
PVL+doxyR-MSSA cutaneous infections after their return
from Côte d’Ivoire confirm that the strain is still dissemi-
nating and is strongly associated with a stay in that coun-
try (Figure).
The infecting MSSA is remarkable in its resistance to
doxycycline, which may favor selection of a preexisting
PVL+doxyR-MSSAin carrier soldiers who are given a pro-
phylactic dose of doxycycline. Because the 2 companies
had no contact with each other before, during, and after
their stay in Côte d’Ivoire, we think that the S. aureus clone
persists in Côte d’Ivoire. Transmission may have occurred
through the persistence of the strain in the environment of
the training camp in Côte d’Ivoire, where hygiene condi-
tions were poor (4 rooms, 3 showers, 3 lavatories for ≈70
soldiers). However, the relatively high prevalence of PVL-
positive MSSA carriage found in our study suggests that
nasal carriage may play an important role in transmission of
these highly virulent microorganisms.
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